Tuesday, 30 April 2013

Stemedica receives patent for ectodermal stem cells

Stemedica Cell Technologies (SCT) announced today that it has received a patent from the United States Patent and Trademark Office named “Culturing Ectodermal Cells Under Reduced Oxygen Tension”. The patent covers SCT's proprietary manufacturing process for enhancing the proliferation and differentiation potential of ectodermal cells of any origin.

You can read the official press release here

No comments:

Post a Comment

Please note that we dont offer any kind of medical advice. Questions requesting specific medical advice (e.g. where can I get this treatment, will this cure XXX condition, etc) will be published but most probably ignored by the administrators. :)

Note to spammers: You shall not pass. If you really want a link from us then consider making a stem cell related guest post !